SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverEL.PA
HealthcareEuronextEUR

EssilorLuxottica

€001234567890012345678900123456789.0012345678900123456789-7.7%
52w low (est.) €137.68€211.49 52w high (est.)
Peers
Market data
Market cap
€78.77B
52-week range
€160.60 – €323.80
Beta (vs market)
0.55
Sector
Healthcare
Valuation
P/E ratio
34.3x
DCF fair value
€83.96
Margin of safety
-50.5%
Forward P/E
21.1x
PEG ratio
1.63
Dividend yield
2.33%
Quality & efficiency
Moat score
63/100
Return on equity
6.1%
Profit margin
8.1%
Debt / equity
0.36
Growth & analysts
Revenue growth (YoY)
+9.4%
Analyst target
€250.61
Target upside
+47.9%
Analysts covering
23

About EssilorLuxottica

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir Optical, eyexpert, iWear, Humanware, Optifog, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native Eyewear and Bolon, and Foster Grant brands. The company also provides vision assessment, eye pathology diagnosis and treatment, finishing equipment, fitting parameter measurement, small tools, and consumables. In addition, it offers SPECTRALIS, a multimodal imaging platform for diagnosis and treatment; RetinAI; Espansione Group; Cellview Imaging; ANTERION, a multidisciplinary all-in-one anterior segment imaging solution for measurements; apparel, footwear and accessories; and high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. Further, the company designs, develops, markets, and maintains diagnostics, refraction, lens edging and mounting instruments for opticians and prescription laboratories, and measurement; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It sells its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and consumers through the network of brick and mortar retail networks and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.

Valuation

ValueGrowthProfitHealthIncome39QUALITY
Overall Rating
42
Reduce
Reduce
Moat Score63
DCF Intrinsic Value
€83.96-50.5% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
€78.77B
P/E Ratio
34.3
Dividend Yield
2.33%
Revenue Growth
+9.4%
Profit Margin
8.1%
ROE
6.1%
Debt / Equity
0.36
Beta
0.55
Beaten Down
vs Healthcare sector:P/E 34 vs 28 Moat 63 vs 7Yield 2.33% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · EL.PA